Aurora Cannabis Inc (TSE:ACB) – Investment analysts at Seaport Global Securities dropped their Q2 2020 earnings estimates for shares of Aurora Cannabis in a research note issued to investors on Monday, November 25th, Zacks Investment Research reports. Seaport Global Securities analyst B. Hundley now anticipates that the company will post earnings per share of ($0.09) for the quarter, down from their previous forecast of ($0.05). Seaport Global Securities also issued estimates for Aurora Cannabis’ Q3 2020 earnings at ($0.07) EPS, Q4 2020 earnings at ($0.07) EPS, FY2020 earnings at ($0.21) EPS and FY2021 earnings at ($0.23) EPS.
Aurora Cannabis (TSE:ACB) last issued its quarterly earnings results on Thursday, November 14th. The company reported C$0.01 EPS for the quarter, beating analysts’ consensus estimates of C($0.04) by C$0.05. The firm had revenue of C$75.25 million for the quarter, compared to analysts’ expectations of C$95.87 million.
Several other equities analysts also recently weighed in on the stock. CIBC reiterated a “neutral” rating and issued a C$7.00 target price on shares of Aurora Cannabis in a research note on Tuesday, September 24th. Pi Financial dropped their price target on shares of Aurora Cannabis from C$7.00 to C$6.00 and set a “buy” rating on the stock in a research note on Wednesday, November 20th. Jefferies Financial Group cut their price objective on shares of Aurora Cannabis from C$14.00 to C$7.00 in a report on Friday, October 11th. Desjardins reduced their price objective on shares of Aurora Cannabis from C$16.50 to C$14.00 and set a “buy” rating for the company in a research note on Friday, September 13th. Finally, Cantor Fitzgerald raised shares of Aurora Cannabis from a “neutral” rating to an “overweight” rating in a report on Friday, November 15th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average price target of C$9.75.
Aurora Cannabis stock traded down C$0.02 during midday trading on Thursday, reaching C$2.95. The stock had a trading volume of 9,103,100 shares, compared to its average volume of 9,577,459. The company has a quick ratio of 0.63, a current ratio of 1.27 and a debt-to-equity ratio of 17.82. The firm has a market capitalization of $3.10 billion and a PE ratio of -8.06. Aurora Cannabis has a 12 month low of C$2.82 and a 12 month high of C$13.67. The firm’s 50-day moving average price is C$3.75 and its 200 day moving average price is C$6.86.
Aurora Cannabis Company Profile
Aurora Cannabis Inc produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.
